Joest Marcus
Lung and Allergy Center Bonn, Germany.
Allergol Select. 2021 May 27;5:157-161. doi: 10.5414/ALX02200E. eCollection 2021.
In the workup of a 55-year-old atopic patient with cough and viscous secretions, we diagnosed an allergic bronchopulmonary aspergillosis (ABPA) on the basis of common diagnostic criteria for adult asthma patients (Rosenberg-Patterson and ISHAM), supported by the use of IgE antibodies against the Aspergillus components Asp f 2, f 4, and f 6. Initial treatment with prednisolone and itraconazole led to remission. In the long-term follow-up, there were few relapses until 2015, which responded well to standard treatment with oral steroids, and since 2016 the patient is in stable remission. The case highlights the valuable contribution of Aspergillus IgE measurements, including the specific IgEs against the components Asp f 1, f 2, f 4, and f 6 in the diagnosis of ABPA.
在对一名55岁患有咳嗽和粘性分泌物的特应性患者进行检查时,我们根据成人哮喘患者的常见诊断标准(罗森伯格 - 帕特森标准和国际人类与动物真菌学会标准),并通过检测针对烟曲霉成分Asp f 2、f 4和f 6的IgE抗体,诊断出一例变应性支气管肺曲霉病(ABPA)。泼尼松龙和伊曲康唑的初始治疗使病情缓解。在长期随访中,直到2015年复发很少,对口服类固醇的标准治疗反应良好,自2016年以来患者病情处于稳定缓解状态。该病例突出了曲霉IgE检测,包括针对成分Asp f 1、f 2、f 4和f 6的特异性IgE在ABPA诊断中的重要作用。